iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$16.58 USD
-0.12 (-0.72%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $16.59 +0.01 (0.06%) 7:38 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
iTeos Therapeutics, Inc. [ITOS]
Reports for Purchase
Showing records 81 - 100 ( 109 total )
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
GSK Collaboration Validates EOS-448; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Inupadenant Monotherapy Continues to Show Clinical Benefit; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
EOS-850 Hints at Potential Patient Selection
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ASCO 2021 Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Inupadenant Data Update Imminent; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
?''448: Top TIGIT to Twosomes, Taking on Titans
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
A Tickle of Activity with anti-TIGIT Antibody
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Will ITOS Show Best-In-Class Anti-TIGIT Monotherapy Data at AACR?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D